Von Eschenbach Holds FDA RIFs At Bay With Reserve Fund, But Staff Stability Remains A Concern
This article was originally published in The Pink Sheet Daily
Executive Summary
PDUFA carry over funds enable FDA to avoid reduction-in-force process.
You may also be interested in...
Nearing Sunsets For SCHIP, PDUFA Raise Chance Of Bypassing Formal House/Senate Conferences
Legislators could use more informal routes to fashioning final legislation of SCHIP/Medicare and FDA reform to meet Sept. 30 expiration deadline.
Nearing Sunsets For SCHIP, PDUFA Raise Chance Of Bypassing Formal House/Senate Conferences
Legislators could use more informal routes to fashioning final legislation of SCHIP/Medicare and FDA reform to meet Sept. 30 expiration deadline.
FDA Reform Bill May Be Delayed Until September; FDA Holds Tight On Staffing Issues
Reauthorization of prescription drug user fees will go down to the wire as health leaders in House and Senate devote attention to child health legislation.